-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
DICE Therapeutics, Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2021 to Q2 2023.
- DICE Therapeutics, Inc. Common Stock, Value, Issued for the quarter ending June 30, 2023 was $5K, a 25% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)